Eli Lilly releases cheaper vials of the weight-loss drug for self-paying patients and cuts the price of two existing doses.
Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to ...
VSee Health (NASDAQ: VSEE), a leading provider of telehealth solutions, partnered with LanguageLine Solutions, the world’s ...
REPEAT: Rocket Doctor Approved as In-Network Provider for New York Medicaid, Expands Partnership with EngageWell to Enhance Care ...
Shares of Hims & Hers Health tumbled 18% premarket on Tuesday as Wall Street analysts questioned the telehealth provider's ...
A series of important developments in the healthcare sector includes Medtronic adapting to tariff threats, Hims & Hers facing ...
Medicare telehealth coverage will end on March 31, affecting rural Oklahomans who rely on online doctor visits.
ADHD Advisor examined data from the Drug Enforcement Administration and other sources to see why the Adderall shortage ...
Hims & Hers co-founder and CEO Andrew Dudum said the company will pivot and focus on different offerings such as its ...
Hims & Hers said on Monday that it may no longer be able to sell compounded versions of the weight-loss drug made by Novo ...
Rural healthcare providers are struggling to modernize their IT infrastructure, with 81% citing budget constraints as the biggest obstacle to adopting new technologies, according to a Feb. 21 report ...